When it comes to owners in the professional sports world, we’ve seen some pretty interesting ways to make money off investments outside of their team–but nothing may top what Ottawa Senators owner Eugene Melnyk is getting involved with.
According to BarStoolSports.com, Melnyk is working on a product called TBS-2–an experimental sexual dysfunction medicine for women dealing with Anorgasmia.”
Less than two years after severing his links with drug-maker Biovail Corp, Eugene Melnyk is again making headlines with an experimental sexual dysfunction medicine delivered in the form of a nasal spray. According to Trimel, TBS-2 is designed to treat a condition known as “Anorgasmia” that affects one in five women and for which there is no approved treatment. The product is described as a “proprietary intra-nasal bio-adhesive gel formulation of testosterone” that was delivered in the study using pre-loaded syringes as a dispenser. Anorgasmia is a type of sexual dysfunction in which a person cannot achieve orgasm, even with adequate stimulation.
If this experiment works out–it’s safe to say Melnyk’s fan base outside of the Ottawa area may become stronger.